LGVN Insider Transactions
Transaction Date (SEC Report ) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
---|---|---|---|---|---|---|---|---|
2023-03-01 | Hashad Mohamed Wa'el Ahmed | officer: Chief Executive Officer | 50,000 | A-Award | A | 50,000 | 0.00 | 0.00 |
2023-01-27 | Hare Joshua | director, 10 percent owner, officer: Chief Scientific Officer | 7,793,263 | S-Sale | D | 20,000 | 4.28 | 85,600.00 |
2023-01-03 | Clavijo James | officer: CFO and Treasurer | 75,649 | F-InKind | D | 1,288 | 3.37 | 4,340.56 |
2023-01-03 | Lehr Paul T | officer: General Counsel, Secretary | 147,042 | F-InKind | D | 1,472 | 3.37 | 4,960.64 |
2022-12-21 | Girolamo Todd C | director | 5,000 | A-Award | A | 5,000 | 3.00 | 15,000.00 |
2022-12-21 | Soffer Donald M | director | 5,000 | A-Award | A | 5,000 | 3.00 | 15,000.00 |
2022-12-21 | Ungaro Ursula | director | 5,000 | A-Award | A | 5,000 | 3.00 | 15,000.00 |
2022-12-21 | LOSORDO DOUGLAS W | director | 5,000 | A-Award | A | 5,000 | 3.00 | 15,000.00 |
2022-12-21 | Hare Joshua | director, 10 percent owner, officer: Chief Scientific Officer | 5,000 | A-Award | A | 5,000 | 3.00 | 15,000.00 |
2022-12-21 | Ross Cathy | director | 5,000 | A-Award | A | 5,000 | 3.00 | 15,000.00 |
2022-12-21 | Soffer Rock | director | 5,000 | A-Award | A | 5,000 | 3.00 | 15,000.00 |
2022-12-21 | Hare Neil E | director | 5,000 | A-Award | A | 5,000 | 3.00 | 15,000.00 |
2022-12-21 | Borger Erin | director | 5,000 | A-Award | A | 5,000 | 3.00 | 15,000.00 |
2022-12-02 | Hare Joshua | director, 10 percent owner, officer: Chief Scientific Officer | 7,813,263 | S-Sale | D | 20,000 | 3.74 | 74,800.00 |
2022-11-16 | Hare Joshua | director, 10 percent owner, officer: Chief Scientific Officer | 7,861,403 | A-Award | A | 48,140 | 0.00 | 0.00 |
2022-11-16 | Lehr Paul T | officer: General Counsel, Secretary | 22,843 | A-Award | A | 22,843 | 4.30 | 98,224.90 |
2022-11-11 | Clavijo James | officer: CFO and Treasurer | 70,649 | G-Gift | D | 5,000 | 0.00 | 0.00 |
2022-10-12 | Hare Joshua | director, 10 percent owner, officer: Chief Scientific Officer | 7,813,263 | S-Sale | D | 100,000 | 3.61 | 361,000.00 |
2022-10-03 | Lehr Paul T | officer: General Counsel, Secretary | 148,514 | F-InKind | D | 1,435 | 3.75 | 5,381.25 |
2022-10-03 | Clavijo James | officer: CFO and Treasurer | 76,937 | F-InKind | D | 1,256 | 3.75 | 4,710.00 |
2022-07-01 | Clavijo James | officer: CFO and Treasurer | 78,193 | F-InKind | D | 1,426 | 5.94 | 8,470.44 |
2022-07-01 | Lehr Paul T | officer: General Counsel, Secretary | 149,949 | F-InKind | D | 1,629 | 5.94 | 9,676.26 |
2022-06-03 | Clavijo James | officer: CFO and Treasurer | 79,619 | S-Sale | D | 36,955 | 8.26 | 305,248.30 |
2022-06-03 | Clavijo James | officer: CFO and Treasurer | 116,574 | A-Award | A | 40,000 | 0.00 | 0.00 |
2022-06-03 | Lehr Paul T | officer: General Counsel, Secretary | 5,000 | A-Award | A | 5,000 | 8.73 | 43,650.00 |
2022-06-03 | Lehr Paul T | officer: General Counsel, Secretary | 151,578 | A-Award | A | 40,000 | 0.00 | 0.00 |
2022-05-24 | Soffer Rock | director | 672,351 | S-Sale | D | 4,000 | 7.50 | 30,000.00 |
2022-05-23 | Soffer Rock | director | 676,351 | S-Sale | D | 8,000 | 7.78 | 62,200.00 |
2022-05-20 | Soffer Rock | director | 684,351 | S-Sale | D | 7,500 | 8.06 | 60,435.00 |
2022-05-17 | Soffer Rock | director | 691,851 | J-Other | A | 500,182 | 0.00 | 0.00 |
2022-05-17 | Soffer Donald M | director | 6,693,737 | J-Other | A | 6,535,223 | 0.00 | 0.00 |
2022-05-17 | Soffer Donald M | director | 0 | J-Other | D | 7,024,208 | 0.00 | 0.00 |
2022-05-17 | DS MED LLC | 10 percent owner | 0 | J-Other | D | 7,024,208 | 0.00 | 0.00 |
2022-04-19 | Hare Joshua | director, 10 percent owner, officer: Chief Scientific Officer | 7,913,263 | S-Sale | D | 78 | 10.00 | 780.00 |
2022-04-18 | Hare Joshua | director, 10 percent owner, officer: Chief Scientific Officer | 7,913,341 | S-Sale | D | 19,922 | 10.00 | 199,289.73 |
2022-04-13 | Soffer Donald M | director | 7,024,208 | J-Other | D | 748,694 | 0.00 | 0.00 |
2022-04-13 | DS MED LLC | 10 percent owner | 7,024,208 | J-Other | D | 748,694 | 0.00 | 0.00 |
2022-04-13 | Soffer Rock | director | 191,669 | J-Other | A | 139,912 | 0.00 | 0.00 |
2022-04-04 | Min Kwan-Hong Christopher | officer: Chief Medical Officer | 50,000 | A-Award | A | 150,000 | 12.85 | 1,927,500.00 |
2022-04-04 | Min Kwan-Hong Christopher | officer: Chief Medical Officer | 2,335 | A-Award | A | 2,335 | 12.85 | 30,004.75 |
2022-04-04 | Min Kwan-Hong Christopher | officer: Chief Medical Officer | 151,978 | A-Award | A | 150,000 | 0.00 | 0.00 |
2022-04-04 | Min Kwan-Hong Christopher | officer: Chief Medical Officer | 1,978 | F-InKind | D | 357 | 0.00 | 0.00 |
2022-04-04 | Min Kwan-Hong Christopher | officer: Chief Medical Officer | 2,335 | A-Award | A | 2,335 | 12.85 | 30,004.75 |
2022-04-04 | Clavijo James | officer: CFO and Treasurer | 76,574 | F-InKind | D | 1,288 | 15.61 | 20,105.68 |
2022-04-04 | Green Geoff | officer: CEO | 133,904 | F-InKind | D | 1,840 | 15.61 | 28,722.40 |
2022-04-04 | Lehr Paul T | officer: General Counsel, Secretary | 111,578 | F-InKind | D | 1,472 | 15.61 | 22,977.92 |
2022-04-04 | Min Kwan-Hong Christopher | officer: Chief Medical Officer | 152,335 | A-Award | A | 150,000 | 0.00 | 0.00 |
2022-04-04 | Min Kwan-Hong Christopher | officer: Chief Medical Officer | 2,335 | A-Award | A | 2,335 | 12.85 | 30,004.75 |
2022-02-25 | Girolamo Todd C | director | 5,000 | A-Award | A | 5,000 | 0.00 | 0.00 |
2022-01-05 | Lehr Paul T | officer: General Counsel, Secretary | 113,050 | F-InKind | D | 3,316 | 12.09 | 40,090.44 |
2022-01-03 | Green Geoff | officer: CEO | 135,744 | F-InKind | D | 3,979 | 12.09 | 48,106.11 |
2022-01-03 | Clavijo James | officer: CFO and Treasurer | 77,862 | F-InKind | D | 1,736 | 12.09 | 20,988.24 |
2021-10-13 | Soffer Rock | director | 51,757 | P-Purchase | A | 12,000 | 3.76 | 45,120.00 |
2021-10-13 | Green Geoff | officer: CEO | 139,723 | P-Purchase | A | 1,000 | 3.81 | 3,810.00 |
2021-10-12 | Hare Joshua | director, 10 percent owner, officer: Chief Scientific Officer | 7,933,263 | P-Purchase | A | 2,500 | 3.69 | 9,225.00 |
2021-10-12 | Soffer Rock | director | 39,757 | P-Purchase | A | 4,000 | 3.57 | 14,280.00 |
2021-10-11 | Soffer Rock | director | 35,757 | P-Purchase | A | 3,900 | 3.45 | 13,455.00 |
2021-10-08 | Hare Joshua | director, 10 percent owner, officer: Chief Scientific Officer | 7,930,763 | P-Purchase | A | 3,015 | 3.39 | 10,220.85 |
2021-10-07 | Lehr Paul T | officer: General Counsel, Secretary | 116,366 | P-Purchase | A | 1,750 | 3.34 | 5,845.00 |
2021-10-07 | Clavijo James | officer: CFO and Treasurer | 79,598 | P-Purchase | A | 5,000 | 3.34 | 16,700.00 |
2021-10-07 | Hare Joshua | director, 10 percent owner, officer: Chief Scientific Officer | 7,927,748 | P-Purchase | A | 1,985 | 3.38 | 6,709.30 |
2021-10-01 | Green Geoff | officer: CEO | 138,723 | F-InKind | D | 43,929 | 3.65 | 160,340.85 |
2021-10-01 | Clavijo James | officer: CFO and Treasurer | 74,598 | F-InKind | D | 19,052 | 3.65 | 69,539.80 |
2021-10-01 | Lehr Paul T | officer: General Counsel, Secretary | 114,616 | F-InKind | D | 38,752 | 3.65 | 141,444.80 |
2021-07-20 | Lehr Paul T | officer: General Counsel, Secretary | 50,000 | A-Award | A | 50,000 | 6.08 | 304,000.00 |
2021-07-20 | Lehr Paul T | officer: General Counsel, Secretary | 153,368 | A-Award | A | 6,167 | 0.00 | 0.00 |
2021-07-20 | Green Geoff | officer: CEO | 75,000 | A-Award | A | 75,000 | 6.08 | 456,000.00 |
2021-07-20 | Green Geoff | officer: CEO | 182,652 | A-Award | A | 8,223 | 0.00 | 0.00 |
2021-07-20 | Clavijo James | officer: CFO and Treasurer | 50,000 | A-Award | A | 50,000 | 6.08 | 304,000.00 |
2021-07-20 | Hare Joshua | director, 10 percent owner, officer: Chief Scientific Officer | 50,000 | A-Award | A | 50,000 | 6.08 | 304,000.00 |
2021-07-20 | Hare Joshua | director, 10 percent owner, officer: Chief Scientific Officer | 7,925,763 | A-Award | A | 12,335 | 0.00 | 0.00 |
2021-06-03 | Ungaro Ursula | director | 5,000 | A-Award | A | 5,000 | 0.00 | 0.00 |
2021-05-12 | Hare Joshua | director, 10 percent owner, officer: Chief Scientific Officer | 7,913,428 | A-Award | A | 5,000 | 0.00 | 0.00 |
2021-05-12 | Soffer Rock | director | 31,857 | A-Award | A | 5,000 | 0.00 | 0.00 |
2021-05-12 | Soffer Donald M | director, 10 percent owner | 158,514 | A-Award | A | 5,000 | 0.00 | 0.00 |
2021-05-12 | Hare Neil E | director | 58,514 | A-Award | A | 5,000 | 0.00 | 0.00 |
2021-02-12 | Soffer Donald M | director | 153,514 | P-Purchase | A | 100,000 | 10.00 | 1,000,000.00 |
2021-02-12 | Soffer Rock | director | 26,857 | P-Purchase | A | 100 | 8.05 | 805.00 |
2021-02-12 | Hare Joshua | director, officer: Chief Scientific Officer | 7,908,428 | P-Purchase | A | 12,000 | 10.00 | 120,000.00 |
2021-02-12 | Hare Joshua | director, officer: Chief Scientific Officer | 7,998,428 | P-Purchase | A | 1,000 | 8.23 | 8,230.00 |
2021-02-12 | Hare Joshua | director, officer: Chief Scientific Officer | 7,997,428 | P-Purchase | A | 102,000 | 10.00 | 1,020,000.00 |
2021-02-11 | Ross Cathy | director | 5,000 | A-Award | A | 5,000 | 0.00 | 0.00 |
2021-02-11 | Borger Erin | director | 0 | D-Return | D | 5,000 | 0.00 | 0.00 |
2021-02-11 | Borger Erin | director | 5,000 | A-Award | A | 5,000 | 0.00 | 0.00 |
2021-02-11 | LOSORDO DOUGLAS W | director | 5,000 | A-Award | A | 5,000 | 0.00 | 0.00 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Group doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Group or anyone involved with Discounting Cash Flows Group will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.